{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:10:13Z","timestamp":1781673013915,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10147-020-01793-9","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T13:04:20Z","timestamp":1603112660000},"page":"126-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score"],"prefix":"10.1007","volume":"26","author":[{"given":"Yoshihiko","family":"Yonekawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9669-5860","authenticated-orcid":false,"given":"Kay","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshisada","family":"Aiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Ebata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Kodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Nagino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"1793_CR1","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jamcollsurg.2009.12.040","volume":"210","author":"MG House","year":"2010","unstructured":"House MG, Ito H, G\u00f6nen M et al (2010) Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1600 patients during two decades at a single institution. J Am Coll Surg 210:744\u2013752","journal-title":"J Am Coll Surg"},{"key":"1793_CR2","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1200\/JCO.2008.20.5278","volume":"27","author":"S Kopetz","year":"2009","unstructured":"Kopetz S, Chang GJ, Overman MJ et al (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27:3677\u20133683","journal-title":"J Clin Oncol"},{"key":"1793_CR3","doi-asserted-by":"publisher","first-page":"8490","DOI":"10.1200\/JCO.2004.00.6155","volume":"23","author":"VP Khatri","year":"2005","unstructured":"Khatri VP, Petrelli NJ, Belghiti J (2005) Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol 23:8490\u20138499","journal-title":"J Clin Oncol"},{"key":"1793_CR4","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/00000658-200206000-00002","volume":"235","author":"MA Choti","year":"2002","unstructured":"Choti MA, Sitzmann JV, Tiburi MF et al (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759\u2013766","journal-title":"Ann Surg"},{"key":"1793_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.hpb.2016.03.001","volume":"18","author":"E Khoo","year":"2016","unstructured":"Khoo E, O\u2019Neill S, Brown E et al (2016) Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases. HPB (Oxford) 18:485\u2013493","journal-title":"HPB (Oxford)"},{"key":"1793_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.surge.2014.07.005","volume":"13","author":"G Nigri","year":"2015","unstructured":"Nigri G, Petrucciani N, Ferla F et al (2015) Neoadjuvant chemotherapy for resectable colorectal liver metastases: what is the evidence? results of a systematic review of comparative studies. Surgeon 13:83\u201390","journal-title":"Surgeon"},{"key":"1793_CR7","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","volume":"371","author":"B Nordlinger","year":"2008","unstructured":"Nordlinger B, Sorbye H, Glimelius B et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371:1007\u20131016","journal-title":"Lancet"},{"key":"1793_CR8","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","volume":"14","author":"B Nordlinger","year":"2013","unstructured":"Nordlinger B, Sorbye H, Glimelius B et al (2013) Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 14:1208\u20131215","journal-title":"Lancet Oncol"},{"key":"1793_CR9","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1007\/s00268-017-4195-0","volume":"42","author":"D Hokuto","year":"2018","unstructured":"Hokuto D, Nomi T, Yasuda S et al (2018) Risk factors for unresectable recurrence after up-front surgery for colorectal liver metastasis. World J Surg 42:884\u2013891","journal-title":"World J Surg"},{"key":"1793_CR10","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.ejso.2015.04.012","volume":"41","author":"N Ayez","year":"2015","unstructured":"Ayez N, van der Stok EP, Gr\u00fcnhagen DJ et al (2015) The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: clinical risk score as possible discriminator. Eur J Surg Oncol 41:859\u2013867","journal-title":"Eur J Surg Oncol"},{"key":"1793_CR11","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/bjs.4160","volume":"90","author":"K Tanaka","year":"2003","unstructured":"Tanaka K, Adam R, Shimada H et al (2003) Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. BJS 90:963\u2013969","journal-title":"BJS"},{"key":"1793_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00534-011-0460-z","volume":"19","author":"T Beppu","year":"2012","unstructured":"Beppu T, Sakamoto Y, Hasegawa K et al (2012) A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a project study for hepatic surgery of the Japanese society of hepato-biliary-pancreatic surgery. J Hepatobiliary Pancreat Sci 19:72\u201384","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"1793_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1478-3231.2008.01845.x","volume":"29","author":"R Konopke","year":"2009","unstructured":"Konopke R, Kersting S, Distler M et al (2009) Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases. Liver Int 29:89\u2013102","journal-title":"Liver Int"},{"key":"1793_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/SLA.0b013e31815aa2c2","volume":"247","author":"M Rees","year":"2008","unstructured":"Rees M, Tekkis PP, Welsh FK et al (2008) Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247:125\u2013135","journal-title":"Ann Surg"},{"key":"1793_CR15","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.3748\/wjg.v12.i39.6305","volume":"12","author":"I Nagashima","year":"2006","unstructured":"Nagashima I, Takada T, Adachi M et al (2006) Proposal of criteria to select candidates with colorectal liver metastases for hepatic resection: comparison of our scoring system to the positive number of risk factors. World J Gastroenterol 12:6305\u20136309","journal-title":"World J Gastroenterol"},{"key":"1793_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1072-7515(99)00089-7","volume":"189","author":"S Iwatsuki","year":"1999","unstructured":"Iwatsuki S, Dvorchik I, Madariaga JR et al (1999) Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 189:291\u2013299","journal-title":"J Am Coll Surg"},{"issue":"3","key":"1793_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","volume":"230","author":"Y Fong","year":"1999","unstructured":"Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230(3):309\u2013318","journal-title":"Ann Surg"},{"key":"1793_CR18","first-page":"1254","volume":"77","author":"B Nordlinger","year":"1996","unstructured":"Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie Cancer 77:1254\u20131262","journal-title":"Association Francaise de Chirurgie Cancer"},{"key":"1793_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/SLA.0b013e3180603039","volume":"246","author":"S Zakaria","year":"2007","unstructured":"Zakaria S, Donohue JH, Que FG et al (2007) Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg 246:183\u2013191","journal-title":"Ann Surg"},{"key":"1793_CR20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/SLA.0000000000002064","volume":"267","author":"K Sasaki","year":"2018","unstructured":"Sasaki K, Morioka D, Conci S et al (2018) The tumor burden score: a new, \u201cmetro-ticket\u201d prognostic tool for colorectal liver metastases based on tumor size and number of tumors. Ann Surg 267:132\u2013141","journal-title":"Ann Surg"},{"key":"1793_CR21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12885-015-1199-8","volume":"15","author":"N Ayez","year":"2015","unstructured":"Ayez N, van der Stok EP, de Wilt H et al (2015) Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial. BMC Cancer 15:180","journal-title":"BMC Cancer"},{"key":"1793_CR22","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1200\/JCO.2006.06.8353","volume":"24","author":"G Portier","year":"2006","unstructured":"Portier G, Elias D, Bouche O et al (2006) Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 24:4976\u20134982","journal-title":"J Clin Oncol"},{"key":"1793_CR23","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s00280-015-2752-5","volume":"75","author":"T Kato","year":"2015","unstructured":"Kato T, Uehara K, Maeda A et al (2015) Phase II multicenter study of adjuvant S-1 for colorectal liver metastasis: survival analysis of N-SOG 01 trial. Cancer Chemother Pharmacol 75:1281\u20131288","journal-title":"Cancer Chemother Pharmacol"},{"key":"1793_CR24","doi-asserted-by":"publisher","first-page":"4906","DOI":"10.1200\/JCO.2008.17.3781","volume":"26","author":"E Mitry","year":"2008","unstructured":"Mitry E, Fields AL, Bleiberg H et al (2008) Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol 26:4906\u20134911","journal-title":"J Clin Oncol"},{"key":"1793_CR25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/jjco\/hyx048","volume":"47","author":"T Mukai","year":"2017","unstructured":"Mukai T, Uehara K, Goto H et al (2017) Phase II trial of neoadjuvant chemotherapy with S-1 and oxaliplatin plus bevacizumab for colorectal liver metastasis (N-SOG 05 trial). Jpn J Clin Oncol 47:597\u2013603","journal-title":"Jpn J Clin Oncol"},{"key":"1793_CR26","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/bjs.10838","volume":"105","author":"GA Margonis","year":"2018","unstructured":"Margonis GA, Sasaki K, Gholami S et al (2018) Genetic and morphological evaluation (GAME) score for patients with colorectal liver metastases. Br J Surg 105:1210\u20131220","journal-title":"Br J Surg"},{"key":"1793_CR27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1470-2045(14)70105-6","volume":"15","author":"J Primrose","year":"2014","unstructured":"Primrose J, Falk S, Finch-Jones M et al (2014) Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial. Lancet Oncol 15:601\u2013611","journal-title":"Lancet Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-020-01793-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-020-01793-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-020-01793-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T06:33:22Z","timestamp":1634625202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-020-01793-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1793"],"URL":"https:\/\/doi.org\/10.1007\/s10147-020-01793-9","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"25 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors had any declaration or interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study was retrospective observational study. Therefore, informed consent was not obtained from all individual participants included in the study and it was approved by the Nagoya University Hospital Institutional Review Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}